Connor, Clark & Lunn Investment Management (CC&L)’s Repare Therapeutics RPTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-25,826
| Closed | -$122K | – | 1650 |
|
|
2024
Q1 | $122K | Buy |
25,826
+9,097
| +54% | +$42.8K | ﹤0.01% | 1453 |
|
|
2023
Q4 | $122K | Buy |
16,729
+1,810
| +12% | +$13.2K | ﹤0.01% | 1305 |
|
|
2023
Q3 | $180K | Buy |
14,919
+3,493
| +31% | +$42.2K | ﹤0.01% | 1248 |
|
|
2023
Q2 | $121K | Buy |
+11,426
| New | +$121K | ﹤0.01% | 1239 |
|